Análisis Argos
GRAL
GRALSin veredicto2 señales de riesgo
GRAIL Inc. · Healthcare
US$ 69.11
precio al 2026-07-04
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
21/100
Sin veredicto
LA RESPUESTA
No tenemos un veredicto de valuación confiable acá: su flujo de caja no permite una estimación sólida. Mirá su calidad y su salud para formarte una idea — preferimos eso a inventarte un número.
Recompensas
Tiene más caja que deuda: balance fuerte.
Riesgos
!Venta significativa de insiders en el último trimestre.
!Balance frágil: la deuda pesa sobre el negocio.
!Altman Z'' en zona roja (-2.79)
!FCF negativo con deuda creciente
VALOR0/6FUTURO6/6PASADO2/6SALUD1/6DIVIDENDO1/6
El Iris de calidad
VALOR0/6FUTURO6/6PASADO2/6SALUD1/6DIVIDENDO1/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial aceptable
SaludBalance frágil
DividendoEl dividendo aún duerme
Score Argos21de 100Sin veredicto
Ingresos15%
US$ 0.2 B
Margen operativo79%
-363%
Flujo de caja libre48%
US$ -0.3 B
Deuda neta
US$ -0.2 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 3.0B
P/E
EV/EBITDA
FCF yield-10.1%
ROIC-16.8%
Margen operativo-363%
Crecim. ingresos+17.2%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

globenewswire.com · 3 jul
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS
SAN FRANCISCO, July 03, 2026 (GLOBE NEWSWIRE) -- On February 20, 2026, GRAIL, Inc. (NASDAQ: GRAL) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri Trial readout. The news caused huge investor losses and triggered a securities class action lawsuit seeking to represent investors who purchased or otherwise acquired shares of GRAIL common stock between May 13, 2025 and February 19, 2026.
globenewswire.com · 3 jul
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, July 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GRAIL, Inc. (“Grail” or “the Company”) (NASDAQ: GRAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before August 4, 2026.
globenewswire.com · 3 jul
GRAL Shareholder News: GRAIL, Inc. Accused of Making Misrepresentations about its Trial Results in Securities Fraud Class Action – Investors Notified to Contact BFA Law
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ:GRAL) and certain of the Company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in GRAIL, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/grail-class-action-lawsuit.
newsfilecorp.com · 2 jul
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL
New York, New York--(Newsfile Corp. - July 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the "Class Period"), of the important August 4, 2026 lead plaintiff deadline. SO WHAT: If you purchased GRAIL common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
fool.com · 2 jul
Prediction: Grail Stock Will Skyrocket to $100 in 1 Year
Grail's stock has dropped more than 40% from its all-time high. It suffered a big setback, but it still has plenty of irons in the fire.
globenewswire.com · 2 jul
ROSEN, A LONGSTANDING FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL
NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”), of the important August 4, 2026 lead plaintiff deadline.
globenewswire.com · 2 jul
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ: GRAL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Grail securities between May 13, 2025 and February 19, 2026, both dates inclusive (the “Class Period”).
feeds.newsfilecorp.com · 2 jul
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New York, New York--(Newsfile Corp. - July 2, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.